Differences in Weight Loss Between Persons on Standard Balanced vs Nutrigenetic Diets in a Randomized Controlled Trial

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 9, 2015, Pages 1625-1632.e1

  Frankwich, Karen A ^a   Egnatios, Jeremy ^b   Kenyon, Mandy L ^c   Rutledge, Thomas R ^c,d   Liao, Patricia S ^a   Gupta, Samir ^a,c   Herbst, Karen L ^a,c   Zarrinpar, Amir ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BMI; Diet; Nutrigenomics; Personalized Medicine

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET THERAPY; FEASIBILITY STUDY; FEMALE; GENETIC RISK; HUMAN; LOW CARBOHYDRATE DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MIDDLE AGED; NUTRIGENETIC GUIDED DIET; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERSONALIZED MEDICINE; POST HOC ANALYSIS; PREDICTIVE VALUE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; STANDARD BALANCED DIET; TREATMENT DURATION; VETERAN; WEIGHT REDUCTION; COMPARATIVE STUDY; DIET; PROCEDURES; TREATMENT OUTCOME; UNITED STATES;

DIET; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; VETERANS; WEIGHT LOSS;

EID: 84939538443     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.02.044     Document Type: Article

References (34)

1. Ogden C.L., Carroll M.D., Kit B.K., et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014, 311:806-814.
2. Finkelstein E.A., Trogdon J.G., Cohen J.W., et al. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff (Millwood) 2009, 28:w822-w831.
3. Picot J., Jones J., Colquitt J.L., et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009, 13:1-190. 215-357, iii-iv.
4. Maes H.H., Neale M.C., Eaves L.J. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997, 27:325-351.
5. Speliotes E.K., Willer C.J., Berndt S.I., et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010, 42:937-948.
6. Frayling T.M., Timpson N.J., Weedon M.N., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
7. Willer C.J., Speliotes E.K., Loos R.J., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009, 41:25-34.
8. Loos R.J., Lindgren C.M., Li S., et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008, 40:768-775.
9. Thorleifsson G., Walters G.B., Gudbjartsson D.F., et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009, 41:18-24.
10. Conti R., Veenstra D.L., Armstrong K., et al. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. Med Decis Making 2010, 30:328-340.
11. Direct-to-consumer genetic tests: misleading test results are further complicated by deceptive marketing and other questionable practices (GAO Publication No. 10-847T) 2010, U.S. Government Accountability Office, U.S. Government Printing Office, Washington, DC.
12. Global Industry Analysts. Future of direct-to-consumer (DTC) genetic testing market remains fraught with challenges. Available at: . Accessed May 5, 2015. http://www.prweb.com/releases/DTC_genetic_testing/direct_to_consumer_tests/prweb9780295.htm.
13. Vakili S., Caudill M.A. Personalized nutrition: nutritional genomics as a potential tool for targeted medical nutrition therapy. Nutr Rev 2007, 65:301-315.
14. Stryjecki C., Mutch D.M. Fatty acid-gene interactions, adipokines and obesity. Eur J Clin Nutr 2011, 65:285-297.
15. Lairon D., Defoort C., Martin J.C., et al. Nutrigenetics: links between genetic background and response to Mediterranean-type diets. Public Health Nutr 2009, 12:1601-1606.
16. Ordovas J.M., Corella D., Demissie S., et al. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 2002, 106:2315-2321.
17. Sonestedt E., Roos C., Gullberg B., et al. Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am J Clin Nutr 2009, 90:1418-1425.
18. Corella D., Peloso G., Arnett D.K., et al. APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Arch Intern Med 2009, 169:1897-1906.
19. Warodomwichit D., Shen J., Arnett D.K., et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity (Silver Spring) 2009, 17:510-517.
20. Memisoglu A., Hu F.B., Hankinson S.E., et al. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 2003, 12:2923-2929.
21. Junyent M., Parnell L.D., Lai C.Q., et al. Novel variants at KCTD10, MVK, and MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study. Am J Clin Nutr 2009, 90:686-694.
22. Smith C.E., Tucker K.L., Arnett D.K., et al. Apolipoprotein A2 polymorphism interacts with intakes of dairy foods to influence body weight in 2 U.S. populations. J Nutr 2013, 143:1865-1871.
23. Goyenechea E., Collins L.J., Parra D., et al. The -11391 G/A polymorphism of the adiponectin gene promoter is associated with metabolic syndrome traits and the outcome of an energy-restricted diet in obese subjects. Horm Metab Res 2009, 41:55-61.
24. AlSaleh A., O'Dell S.D., Frost G.S., et al. Single nucleotide polymorphisms at the ADIPOQ gene locus interact with age and dietary intake of fat to determine serum adiponectin in subjects at risk of the metabolic syndrome. Am J Clin Nutr 2011, 94:262-269.
25. Ortega-Azorin C., Sorli J.V., Asensio E.M., et al. Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. Cardiovasc Diabetol 2012, 11:137.
26. Huang T., Qi Q., Li Y., et al. FTO genotype, dietary protein, and change in appetite: the Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr 2014, 99:1126-1130.
27. Nettleton J.A., Steffen L.M., Ballantyne C.M., et al. Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and white adults. Atherosclerosis 2007, 194:e131-e140.
28. Bouchard-Mercier A., Godin G., Lamarche B., et al. Effects of peroxisome proliferator-activated receptors, dietary fat intakes and gene-diet interactions on peak particle diameters of low-density lipoproteins. J Nutrigenet Nutrigenomics 2011, 4:36-48.
29. Kinsinger L.S., Jones K.R., Kahwati L., et al. Design and dissemination of the MOVE! weight-management program for veterans. Prev Chronic Dis 2009, 6:A98.
30. Urbaniak GC, Plous S. Research Randomizer (version 4.0) [computer software]. Available at: . Accessed June 22, 2013. http://www.randomizer.org/.
31. Kahwati L.C., Lance T.X., Jones K.R., et al. RE-AIM evaluation of the Veterans Health Administration's MOVE! weight management program. Transl Behav Med 2011, 1:551-560.
32. de las Fuentes L., Waggoner A.D., Mohammed B.S., et al. Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J Am Coll Cardiol 2009, 54:2376-2381.
33. Del Re A.C., Maciejewski M.L., Harris A.H. MOVE: weight management program across the Veterans Health Administration-patient- and facility-level predictors of utilization. BMC Health Serv Res 2013, 13:511.
34. Stanek E.J., Sanders C.L., Taber K.A., et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther 2012, 91:450-458.